Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2Jasmina Makarević, Roman A. Blaheta, Jochen Rutz et al.|PLoS ONE|2014Cited by 93
CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot StudyIgor Tsaur, Roman A. Blaheta, Michael Reiter et al.|Cancer Research and Treatment|2014Cited by 60
Cross‐communication between histone H3 and H4 acetylation and Akt‐m<scp>TOR</scp> signalling in prostate cancer cellsJasmina Makarević, Roman A. Blaheta, Nassim Tawanaie et al.|Journal of Cellular and Molecular Medicine|2014Cited by 29
Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with <scp>RAD</scp>001 (everolimus) or sorafenibEva Juengel, Roman A. Blaheta, Dana Kim et al.|Journal of Cellular and Molecular Medicine|2014Cited by 29
Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent MechanismEva Juengel, Roman A. Blaheta, Jasmina Makarević et al.|Neoplasia|2014Cited by 21